SGO: Targeted Agent Has Activity in Vulvar Cancer (CME/CE)

posted on Mar 22 by MedPage Today OB/Gyn in the Uncategorized category SAN FRANCISCO (MedPage Today) -- Twelve of 14 patients with locally advanced or recurrent vulvar cancer responded or had stable disease during neoadjuvant therapy with erlotinib (Tarceva), according to a study reported here.